Kencur — Benefits Deep Dive

Kencur (Kaempferia galanga) has one of the more distinctive evidence profiles on this site: a single dominant chemical — ethyl p-methoxycinnamate (EPMC) — running through nearly every laboratory finding, a genuinely large and fast-growing body of rodent and cell-culture research (over 40 papers just since 2023), and, as of this review, still not one controlled human trial of any kind for any indication. The four pages below go deeper than the main Kencur page into what that laboratory evidence actually contains: the anti-inflammatory and pain pharmacology behind EPMC, a body of gastric-protective and blood-sugar research the main page does not cover at all, the antimicrobial and oral wound-healing literature (including a case where a paper's title claims more for kencur than its own results support), and the real, verified sedative pharmacology that sits awkwardly beside the herb's occasional marketing as an energy or athletic aid.

Deep-Dive Articles

Pain and Inflammation: The EPMC Pharmacology

The deepest evidence base kencur has: ethyl p-methoxycinnamate's action on leukotriene B4, NF-κB, and nitric oxide production, six new phenylpropanoid compounds isolated since 2024, a dual anti-viral/anti-inflammatory effect against dengue, a 2026 head-to-head trial against diclofenac in mice, and a separate, unrelated vasorelaxant mechanism in blood vessels. Also: what a rodent pain-model positive does and does not tell you, and a fresh safety screen on EPMC's liver, neuron, and cardiac-channel effects.

Digestive Health and the Beras Kencur Tradition

What the jamu beras kencur tradition actually claims, set against real gastric-ulcer protection in two separate rat models, in-vitro inhibition of Helicobacter pylori, and a research cluster the main Kencur page does not mention at all: a newly discovered family of diarylheptanoids from kencur rhizome that stimulate GLP-1 secretion and inhibit alpha-glucosidase — plus why beating acarbose in a test tube is a long way from a diabetes treatment.

Antimicrobial Properties and Oral Wound Healing

Direct antibacterial testing of kencur rhizome and its kaempferide content, a concentrated 2022–2024 Thai and Indonesian research program building mouth gels from isolated kencur diterpenes for oral ulcers, and one real animal trial in which a kencur extract outperformed a steroid comparator. Also a case study in reading a paper's actual results rather than its title: an "antimicrobial Zingiberaceae oils" study whose positive findings belong to two Curcuma species tested alongside kencur, not to kencur itself.

Sedative Pharmacology and the Energy-Marketing Myth

Kencur is occasionally marketed alongside energy and athletic-performance claims — territory that actually belongs to a different species, black ginger. A direct PubMed search for kencur and exercise, fatigue, or athletic performance returns zero results. What the real pharmacology shows instead, confirmed by two independent studies using two different routes of administration, is a CNS depressant: sedative, not stimulant. Includes the two black-ginger human trials, for direct comparison.

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. The Shape of Kencur's Evidence, in One Paragraph
  3. Research Papers: Pain and Inflammation
  4. Research Papers: Digestive and Metabolic
  5. Research Papers: Antimicrobial and Oral
  6. Research Papers: Sedative Pharmacology
  7. External Authoritative Resources
  8. Connections

The Shape of Kencur's Evidence, in One Paragraph

Before the four deep dives, it is worth stating plainly what kind of evidence base this is, because it does not look like the evidence base of a well-studied Western herb. Kencur's research output is large (well over 100 PubMed-indexed papers), recent (nearly a quarter of everything ever published on this plant appeared in 2024–2026), and almost entirely preclinical: rodent models, isolated cell lines, and in-vitro enzyme assays, run mostly by pharmacognosy and food-science laboratories in Thailand, Indonesia, China, and India. This review searched specifically — using PubMed's title/abstract field, phrase-locked to Kaempferia galanga so results are not diluted by its frequently confused relative Kaempferia parviflora (black ginger) — for any human clinical trial, of any kind, for any indication. That search returns papers that mention "human" only because they tested a human cell line in a dish (HepG2 liver cells, human gingival fibroblasts, human lymphocytes) or a human pathogen (Helicobacter pylori is described in one abstract as "the human carcinogen"). None of the 25 hits is an actual trial on human subjects. The main Kencur page's statement that human trial evidence is "essentially none" is accurate, not out of date — a distinction worth stating explicitly, because on other herbs in this same review batch, an identical-sounding claim on the existing hub page turned out to be exactly the kind of thing that goes stale as new research is published. Here, it has not.

What follows across the four pages is therefore laboratory evidence, read carefully and reported for what it is: real chemistry, real animal pharmacology, a handful of surprising and very recent findings the main page does not yet cover, and, in at least two places, a citation trail that leads somewhere other than where a headline would suggest.

Back to Table of Contents

Research Papers: Pain and Inflammation

  1. Dwita LP, Hikmawanti NPE, Yeni, et al. Extract, fractions, and ethyl-p-methoxycinnamate isolate from Kaempferia galanga elicit anti-inflammatory activity by limiting leukotriene B4 production. Journal of Traditional and Complementary Medicine, 2021. — PubMed
  2. Sukkasem K, Itharat A, et al. Anti-inflammatory activities of the Thai remedy Kheaw-Hom and its bioactive compound, ethyl p-methoxycinnamate. Journal of Ethnopharmacology, 2024. — PubMed
  3. Sarmoko, Suprahman NY, et al. Ethyl p-methoxycinnamate exhibits superior multi-modal anti-inflammatory activity compared to structurally related cinnamic acid derivatives. Journal of Pharmacopuncture, 2026. — PubMed
  4. Tao SF, Gongpan P, et al. Six unusual monoterpene-phenylpropanoid cycloadducts from Kaempferia galanga with anti-inflammatory activity. Fitoterapia, 2026. — PubMed
  5. Srivastava N, Mishra S, et al. Standardization of Kaempferia galanga rhizome and vasorelaxation effect of its key metabolite ethyl p-methoxycinnamate. Journal of Ethnopharmacology, 2021. — PubMed
  6. Kasemnitichok Y, Lee S, et al. Insights into hepatic, neuronal, and hERG channel safety of plant-derived active compounds (includes EPMC). Journal of Xenobiotics, 2025. — PubMed
  7. Full citation list, including the dengue-virus finding, the 2026 sinusitis model, and the 2004 toxicology study: see the Pain and Inflammation page, which lists 13 papers individually.

Back to Table of Contents

Research Papers: Digestive and Metabolic

  1. Liu H, Chen Y, et al. Protective effects of an alcoholic extract of Kaempferia galanga rhizome on ethanol-induced gastric ulcer in mice. Journal of Ethnopharmacology, 2024. — PubMed
  2. Bhamarapravati S, Pendland SL, Mahady GB. Extracts of spice and food plants from Thai traditional medicine inhibit the growth of Helicobacter pylori. In Vivo, 2003. — PubMed
  3. Wang T, Wu SL, et al. Diarylheptanoids with hypoglycemic potency from the rhizomes of Kaempferia galanga. Fitoterapia, 2023. — PubMed
  4. Wu SL, Wang T, et al. Antidiabetic constituents of Kaempferiae rhizoma: diarylheptanoid dimers promoting GLP-1 secretion via the PKA-CREB pathway. Phytochemistry, 2025. — PubMed
  5. Lin L, Zhou X, et al. Extracellular vesicles derived from Kaempferia galanga show promise for targeted oral therapy in ulcerative colitis. Journal of Nanobiotechnology, 2025. — PubMed
  6. Full citation list, including the self-microemulsion gastric-ulcer study, the TGR5 bile-acid receptor finding, and the 1997 hypolipidemic study: see the Digestive Health page, which lists 11 papers individually.

Back to Table of Contents

Research Papers: Antimicrobial and Oral

  1. Wahyuni IS, Sufiawati I, et al. Anti-inflammatory activity and wound healing effect of Kaempferia galanga rhizome on chemical-induced oral mucosal ulcer in Wistar rats. Journal of Inflammation Research, 2022. — PubMed
  2. Iadnut A, Sae-Lee T, Tewtrakul S. Wound healing potential of mouth gel containing isopimarane diterpene from Kaempferia galanga rhizomes for oral stomatitis. PeerJ, 2024. — PubMed
  3. Tara Shanbhag V, Chandrakala S, et al. Wound healing activity of alcoholic extract of Kaempferia galanga in Wistar rats. Indian Journal of Physiology and Pharmacology, 2006. — PubMed
  4. Wang Q, Ye J, Wang W. Bacteriostasis of kaempferide on foodborne pathogenic bacteria, tested alongside Kaempferia galanga extract. Electrophoresis, 2025. — PubMed
  5. Mekseepralard C, Kamkaen N, Wilkinson JM. Antimicrobial and antioxidant activities of traditional Thai herbal remedies for aphthous ulcers (includes K. galanga). Phytotherapy Research, 2010. — PubMed
  6. Full citation list, including the kaempulchraol K mouth-gel studies, the mucoadhesive gel formulation, and the paper whose antibacterial results belong to a different genus tested alongside kencur: see the Antimicrobial and Oral Wound Healing page, which lists 11 papers individually.

Back to Table of Contents

Research Papers: Sedative Pharmacology

  1. Ali MS, Dash PR, Nasrin M. Study of sedative activity of different extracts of Kaempferia galanga in Swiss albino mice. BMC Complementary and Alternative Medicine, 2015. — PubMed
  2. Huang L, Yagura T, Chen S. Sedative activity of hexane extract of Kaempferia galanga and its active compounds, by inhalation. Journal of Ethnopharmacology, 2008. — PubMed
  3. Fujiwara Y, Ito M. Synergistic effect of fragrant herbs in Japanese scent sachets (includes galangal, K. galanga). Planta Medica, 2015. — PubMed
  4. Promthep K, Eungpinichpong W, et al. Effect of Kaempferia parviflora extract on physical fitness of soccer players — a randomized trial (black ginger, the other Kaempferia species). Medical Science Monitor Basic Research, 2015. — PubMed
  5. Ekasari W, Widyowati R, et al. Exploration of traditional herbs to overcome cough and cold in three provinces of East Java (K. galanga is the most-cited plant for cough). The Scientific World Journal, 2025. — PubMed
  6. Full citation list, including the second black-ginger safety trial and the CNS-depression toxicology findings: see the Sedative Pharmacology page, which lists 11 papers individually.

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents